Pfizer and BioNTech announce joint development of a potential COVID-19 vaccine
https://techcrunch.com/2020/03/17/pfizer-and-biontech-announce-joint-development-of-a-potential-covid-19-vaccine/
Pharma giant Pfizer announced on Tuesday that it’s working with BioNTech, a German company working on new kinds of immunotherapy treatments, on a potential COVID-19 vaccine. The joint effort, confirmed Tuesday via a signed letter of intent, will see both partners work together on a a messenger RNA-based vaccine that will seek to prevent people from contracting the new coronavirus.
It’s worth a reminder that any vaccine is going to take, at minimum, between a year and 18 months to develop and certify for general. human use, so don’t think that this is going to result in any kind of short-term solution. But the collaboration does bring together one of the largest and most established players in the realm of pharmaceutical biotech, along with a younger company working at the forefront of mRNA-based immune therapies.